Author

Alexandre Bernard

Institutions: Institut de Cancérologie Strasbourg, Institute for Research in Immunology and Cancer, Université de Montréal

Observed institutions: Institut de Cancérologie Strasbourg, Institute for Research in Immunology and Cancer, Institut Strauss, Université de Montréal

ORCID: 0000-0001-7149-0965

Observed ORCID: 0000-0001-7149-0965

OpenAlex ID: A5085429908

Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation

2021 · Paul-Michel Mertes, Olivier Collange, et al. · Journal of Controlled Release · 21

Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations

2023 · Karine Normandin, Jasmin Coulombe-Huntington, et al. · PLoS Genetics · 15

Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study

2023 · Carinato Hélène, Ombline Conrad, et al. · BMC Cancer · 4

Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects

2023 · Marie‐Charlotte Diringer, Pierre Coliat, et al. · Small · 4

Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects (Small 12/2023)

2023 · Marie‐Charlotte Diringer, Pierre Coliat, et al. · Small

LEAF- 4L6715 enhances oxygenation in patients with acute respiratory distress syndrome (ARDS) due to severe COVID-19: Final results of a phase I/II clinical trial

2022 · Paul-Michel Mertes, Xavier Delabranche, et al. · medRxiv

Works count: 6

Citation count: 44

H-index: 4

I10-index: 2